Study of Visual-spatial Attention by Eye Tracking as a Function of Central or Peripheral Visual Impairment
NCT ID: NCT03505398
Last Updated: 2024-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
71 participants
INTERVENTIONAL
2018-05-15
2023-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Perception Exploration Using Eye-tracking Technology in High-fidelity Medical Simulation
NCT03049098
Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects
NCT06914505
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
NCT03319966
Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance
NCT05703360
Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study
NCT05865093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
central vision disorder
microperimetry
define the retinal fixation point and the differential sensitivity threshold of the retina.
visual acuity
using ETDRS scales
automated visual field
recording visual attention based on central or peripheral visual information
eye movements recording
recording of explicit visual attention based on central or peripheral visual information
peripheral vision disorder
microperimetry
define the retinal fixation point and the differential sensitivity threshold of the retina.
visual acuity
using ETDRS scales
automated visual field
recording visual attention based on central or peripheral visual information
eye movements recording
recording of explicit visual attention based on central or peripheral visual information
control
microperimetry
define the retinal fixation point and the differential sensitivity threshold of the retina.
visual acuity
using ETDRS scales
automated visual field
recording visual attention based on central or peripheral visual information
eye movements recording
recording of explicit visual attention based on central or peripheral visual information
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
microperimetry
define the retinal fixation point and the differential sensitivity threshold of the retina.
visual acuity
using ETDRS scales
automated visual field
recording visual attention based on central or peripheral visual information
eye movements recording
recording of explicit visual attention based on central or peripheral visual information
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a central visual deficit (central scotoma on the visual field: DMLA, cones dystrophy ...) or peripheral (annular scotoma: chronic glaucoma, retinitis pigmentosa ...) or without visual deficit (corrected visual acuity and visual field)
* Patient agreeing to participate in the study and signing informed consent
* Patient affiliated to social security
Exclusion Criteria
* Patient with known epilepsy
* Major under judicial safeguard, or deprived of liberty
* Major under guardianship or curatorship or admitted to a health or social institution for purposes other than research.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A00977-46
Identifier Type: OTHER
Identifier Source: secondary_id
RC17_0134
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.